Table 3.
Populations | Sex | β-coefficient | 95% CI | Risk allele carriers, ng/dL | Nonrisk homozygotes, ng/dL | P interaction |
---|---|---|---|---|---|---|
A whole cohort of African descent (n = 61) | Female | –3.70 | –6.85 to –0.56 | 4.81 ± 1.09 | 8.51 ± 1.02 | .023 |
Male | 2.10 | –1.78 to 5.99 | 5.85 ± 1.01 | 3.75 ± 1.45 | ||
Age > 50 y (n = 19) | Female | 0.52 | –4.17 to 5.22 | 5.11 ± 1.19 | 4.59 ± 1.05 | .63 |
Male | –2.84 | –17.62 to 11.93 | 5.23 ± 2.74 | 8.08 ± 3.63 | ||
Age ≤ 50 y (n = 42) | Female | –5.9 | –10.34 to –1.47 | 4.64 ± 1.43 | 10.36 ± 1.34 | .007 |
Male | 2.35 | –1.68 to 6.38 | 5.21 ± 1.00 | 2.86 ± 1.51 |
Data represent least square mean ± SEM. Multiple regression analysis for aldosterone level response to angiotensin II infusion was adjusted for age, body mass index, sites, and disease status.
Abbreviation: LSD1, lysine-specific demethylase 1.